Senate Quicksand Engulfs a Bipartisan Plan That Trump Backs

President Donald Trump has vowed to lower the cost of prescription drugs. A Senate committee has approved a bipartisan bill to do just that. And the plan is going nowhere fast.

Read More

Trump’s Drug Importation Plan Faces Resistance in US, Canada

President Trump’s proposal to import cheaper prescription drugs from Canada faces significant headwinds from U.S. pharmaceutical companies and the Canadian government.

Read More

Headline Risk Will Remain High for US Healthcare In 2020

Demand drivers for US healthcare will remain intact in 2020 with most companies managing profitability pressures but headline risk remains, says Fitch Ratings. Headline risk will be high due to the overhang of opioid litigation liabilities, Affordable Care Act (ACA) court decisions and election rhetoric. Business models may continue to evolve given the slowly changing payment landscape.

Read More

Candidates Are Betting Big On Health. Is That What Voters Really Want?

The one thing we know about health care in the 2020 Democratic presidential primary race is that it’s a top issue for voters.

Read More

Medical Device Failures Brought To Light Now Bolster Lawsuits And Research

Lorraine Bonner felt as though she was the only one. The surgical staples used to seal her colon after surgery had leaked, she has alleged in a lawsuit, spurring additional surgeries and a long, difficult recovery.

Read More

Health Care Costs for California Workers Are Growing Far Faster Than Incomes

Californians who get health insurance through their jobs are having to spend a greater share of their paychecks on health care costs, according to a new analysis of employer-sponsored health plans to be released Thursday by the Commonwealth Fund, a nonprofit foundation that researches health industry trends.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square